ANGI
Angi Inc.
ANGI trails on the overall score without a compensating advantage in the available component scores.
META
Meta Platforms, Inc.
META has the edge over ANGI overall, supported by stronger fundamentals and lower modeled downside.
ANGI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Under pressure |
ANGI's revenue, profitability, cash flow and balance sheet are all currently under pressure.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
ANGI PE Valuation
ANGI has no meaningful PE right now: it lost money over the past year.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
ANGI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Decline | |
| Improving | |
| Limited | |
| Low |
Analysts expect ANGI's earnings to grow and its profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
ANGI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.41 | — |
| Q3 2026 | -$5.71 | -965% |
| Q2 2026 | -$5.51 | -588% |
| Q1 2026 | $0.42 | -58% |
| Q4 2025 | $0.94 | +34% |
| Q3 2025 | $0.66 | -5.7% |
| Q2 2025 | $1.13 | +$1.23 |
| Q1 2025 | $1.00 | +$1.50 |
| Q4 2024 | $0.70 | +$1.50 |
ANGI has swung to a loss: it lost $5.71 per share over the past year, after a profit the year before.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the edge over ANGI on earnings quality, reporting a profit while its opponent remains loss making.
ANGI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $242M | -8.9% |
| Q2 2026 | $248M | -11% |
| Q1 2026 | $238.2M | -3.2% |
| Q4 2025 | $240.8M | -10% |
| Q3 2025 | $265.6M | -10% |
| Q2 2025 | $278.2M | -12% |
| Q1 2025 | $245.9M | -19% |
| Q4 2024 | $267.9M | +22% |
ANGI's revenue has slid since its 2022 peak: $242M last quarter, down 8.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.4% | -1.8 points |
| Q2 2026 | -94% | -101 points |
| Q1 2026 | -4% | -12 points |
| Q4 2025 | 2.5% | +1.7 points |
| Q3 2025 | 8.2% | +5.6 points |
| Q2 2025 | 6.3% | +3.4 points |
| Q1 2025 | 8.1% | +7.2 points |
| Q4 2024 | 0.8% | -4.1 points |
ANGI's operating margin was 6.4% last quarter, down 1.8 points from the same quarter a year ago.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over ANGI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over ANGI on profitability, with a higher operating margin.
ANGI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.4M | +192% |
| Q2 2026 | $12.2M | -73% |
| Q1 2026 | -$33.6M | -$17.9M |
| Q4 2025 | $11.4M | -58% |
| Q3 2025 | $4.9M | -74% |
| Q2 2025 | $44.9M | -10% |
| Q1 2025 | -$15.7M | -265% |
| Q4 2024 | $27.1M | +$33.4M |
ANGI still generates free cash flow, though less than at its 2020 peak: $4M over the past year.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META has the edge over ANGI on cash flow, with more consistent year-over-year improvement.
ANGI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.6% | +659K shares |
| 1 year | -8.9% | -4M shares |
| 3 years | -19% | -9.5M shares |
| 5 years | -18% | -9.2M shares |
| Available history | -21% | -10.7M shares |
ANGI has the edge over META on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $46M |
| Q3 2025 | $26.3M |
| Q2 2025 | $66.6M |
| Q1 2025 | $9.8M |
| Q4 2024 | $2.9M |
ANGI spent $46M buying back its own shares over the past year, down 56% from the year before.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
ANGI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 0.7x | Very low |
| Q3 2024 | 0.9x | Very low |
| Q2 2024 | 1.0x | Healthy |
ANGI's net debt is about 2.6 years of its operating earnings (EBITDA), up from a year a year ago.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
ANGI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.8 | Neutral |
| Stochastic | 69.1 | Neutral |
ANGI's weekly RSI is 50 (neutral) and its Stochastic is 69 (neutral).
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
ANGI PE vs Communication Services Sector
| Metric | ANGI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 16x | — |
ANGI has no meaningful PE right now: it lost money over the past year.
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
ANGI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.26 | 1.1% above |
| 20 week MA | $5.71 | 11% above |
| 50 week MA | $7.58 | 16% below |
| 100 week MA | $11.6 | 45% below |
| 200 week MA | $18.0 | 65% below |
ANGI has the edge over META on trend strength, trading above more of its moving averages.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
ANGI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $83.6 | $132.7 | +59% |
| 2021 | $132.7 | $94.3 | -29% |
| 2022 | $94.3 | $22.3 | -76% |
| 2023 | $22.3 | $24.9 | +12% |
| 2024 | $24.9 | $16.5 | -34% |
| 2025 | $16.5 | $12.7 | -23% |
| 2026 YTD | $12.7 | $6.33 | -50% |
ANGI has finished lower in four of the last six years. It's down 50% so far in 2026.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META has the edge over ANGI on returns for 2026, with the stronger performance.